The grouping of clusters around the different targets, e.g., TNFi and IL-6, vs no distinct clusters or highly mixed clusters suggests that subjects may be grouped by the dominant pathway driving their RA disease activity. The gene discussed is IL6; the disease is rheumatoid arthritis.